CLOs on the Move

Penn Foundation

www.pennfoundation.org

 
Founded in 1955 and located on a 30-acre campus in Sellersville, Pennsylvania, Penn Foundation is a not-for-profit organization providing innovative services that address the mental health, substance use, and intellectual disability needs of our community. Through a broad range of diverse programs that can be tailored to meet individual needs, Penn Foundation provides compassionate, responsive care to more than 10,000 children, adolescents, and adults each year. Our tradition of compassionate care combined with a strong belief in the healing power of hope and the possibility of recovery enables us to help individuals and families grow, develop, and recover to their ...
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Royal Ottawa Health Care Group

Royal Ottawa Health Care Group is a Ottawa, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

San Luis Valley HMO

San Luis Valley HMO is a Alamosa, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Florida's Blood Center

Founded in 1942 FBC is now the sole supplier of blood products to 70 healthcare facilities in a 22-country area. Annually, more than 350000 pints of blood are collected from volunteers. FBC is the fourth largest independent blood bank in the nation.

American Health Care

American Health Care is a San Bernardino, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fractyl Laboratories

At Fractyl, we are focused on improving the health of people with Type 2 diabetes. We`ve created an innovative clinical procedure based on new insights into the root cause of the disease. We are currently engaged in clinical trials designed to prove that our innovative procedure can dramatically improve glucose control and reduce the need for additional medications. Our mission is to set people free from the daily burdens of Type 2 diabetes management, empower physicians with a safe and reliable therapeutic treatment, and lower the tremendous human and financial costs of diabetic complications for patients, hospitals, and payers.